Inovio prices $65m senior notes offering

This article was originally published here

Inovio - updated logoInovio Pharmaceuticals (NSDQ:INO) said today that it priced an offering of $65 million of 6.5% convertible senior notes due 2024.

The Plymouth Meeting, Penn.-based company also gave initial purchasers a 13-day option to buy up to an additional $20 million in notes.

Get the full story at our sister site, Drug Delivery Business News.

The post Inovio prices $65m senior notes offering appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply